FMR CORP 13D and 13G filings for Axonics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 12:03 pm Sale |
2024-02-09 | 13G | Axonics, Inc. AXNX |
FMR CORP | 1,179,132 2.322% |
-4,246,873 (-78.27%) |
Filing |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Axonics, Inc. AXNX |
FMR CORP | 5,426,005 10.710% |
-91,421 (-1.66%) |
Filing |
| 2023-12-11 09:09 am Purchase |
2023-12-08 | 13G | Axonics, Inc. AXNX |
FMR CORP | 5,517,426 10.890% |
2,798,634 (+102.94%) |
Filing |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | Axonics, Inc. AXNX |
FMR CORP | 2,718,792 5.489% |
-1,200,592 (-30.63%) |
Filing |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | Axonics, Inc. AXNX |
FMR CORP | 3,919,384 8.465% |
-938,522 (-19.32%) |
Filing |
| 2021-02-08 10:17 am Purchase |
2021-02-05 | 13G | Axonics, Inc. AXNX |
FMR CORP | 4,857,906 12.202% |
168,080 (+3.58%) |
Filing |
| 2020-10-13 10:35 am Purchase |
2020-10-12 | 13G | Axonics, Inc. AXNX |
FMR CORP | 4,689,826 11.866% |
4,241,066 (+945.06%) |
Filing |